Advertisement

NLA Journal Club

Clinical Utility of Genetic Testing in the Diagnosis of Familial Hypercholesterolemia

Presented by Amy C. Sturm, MS, LGC, Peter H. Jones, MD and Alan S. Brown, MD

Support provided by Quest Diagnostics

 
   

Recommendations on Treatment with PCSK9 Inhibitors

Presented by Carl E. Orringer, MD, FACC, FNLA and Alan S. Brown, MD, FACC, FAHA, FNLA, FASPC

 
   

FOURIER trial: Understanding the Role of PCSK9 Inhibitors in ASCVD Patients​

Presented by Daniel Soffer, MD, FNLA, FACP and Alan S. Brown, MD, FACC, FAHA, FNLA, FASPC

 
   
0
No votes yet
Publish Date: 
Friday, May 19, 2017 - 15:30

Lipid Insights

These are some older Journal Club programs initially published under the name Lipid Insights.
Content Level Original Air Date
Lipid Insights: A Case Study in Dyslipidemia Management- Incorporating the NLA Recommendations into Practice 2 - Level 2 (CORE) Tuesday, November 11, 2014
Lipid Insights: NLA Patient Centered Treatment Recommendations 2 - Level 2 (CORE) Friday, October 10, 2014
Lipid Insights: Lysosomal Acid Lipase (LAL) Deficiency 3 - Level 3 (INTERMEDIATE) Monday, December 9, 2013
Lipid Insights: New Therapies for HoFH 2 - Level 2 (CORE) Tuesday, March 12, 2013
Analysis of a Study: Emerging Therapies for HoFH 2 - Level 2 (CORE) Tuesday, December 18, 2012
The Role of Omega-3's in Cardiovascular Disease 2 - Level 2 (CORE) Tuesday, November 27, 2012
CETP Inhibition - An Important Potential Strategy in Reducing Cardiovascular Events 2 - Level 2 (CORE) Thursday, September 6, 2012
The Effects of Statin Therapy on Diabetes Incidence and Glycemic Control 2 - Level 2 (CORE) Wednesday, May 16, 2012
Should We Continue to AIM-HIGH or Set Our Sights Low? 2 - Level 2 (CORE) Thursday, December 15, 2011
Dietary Approaches to Weight Management: Efficacy and Metabolic Effects 2 - Level 2 (CORE) Tuesday, September 20, 2011

Copyright © 2018 National Lipid Association. All Rights Reserved.

Privacy Policy Terms of Service